Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson.Scientists will begin recruiting some 6,000 people across the U.K.
on Monday for the 12-month trial. Moderna’s coronavirus vaccine is 94.5% effective, company says Dr. Saul Faust, who is helping lead the study, said the research will start first in Britain but aims to recruit a total of 30,000 people in six countries around the world.The shot uses a harmless cold virus to deliver the spike protein of the coronavirus into the body, which scientists hope will prompt an immune response.Faust said the news from Pfizer and its German partner BioNTech last.